Midwest Professional Planners, Ltd. Bio N Tech Se Transaction History

Midwest Professional Planners, Ltd.

$324 Million
Q4 2024

A detailed history of Midwest Professional Planners, Ltd. transactions in Bio N Tech Se stock. As of the latest transaction made, Midwest Professional Planners, Ltd. holds 4,051 shares of BNTX stock, worth $485,431. This represents 0.14% of its overall portfolio holdings.

Number of Shares

4,051

Previous 3,829 5.8%

Holding current value

$485,431

Previous $454,000 1.54%

% of portfolio

0.14%

Previous 0.14%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$99.72 - $122.68 $22,137 - $27,234	222 Added 5.8%	4,051 $461,000
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $5,877 - $9,349	-75 Reduced 1.92%	3,829 $454,000
Q2 2024 Aug 06, 2024	BUY	$80.36 - $102.87 $58,421 - $74,786	727 Added 22.88%	3,904 $313,000
Q1 2024 May 09, 2024	BUY	$88.96 - $112.35 $18,859 - $23,818	212 Added 7.15%	3,177 $293,000
Q4 2023 Feb 15, 2024	BUY	$90.91 - $112.75 $13,000 - $16,123	143 Added 5.07%	2,965 $312,000
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $21,670 - $27,517	220 Added 8.46%	2,822 $306,000
Q2 2023 Aug 07, 2023	BUY	$102.58 - $129.66 $33,133 - $41,880	323 Added 14.17%	2,602 $280,000
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $18,753 - $23,511	153 Added 7.2%	2,279 $283,000
Q4 2022 Feb 10, 2023	BUY	$118.43 - $186.05 $28,541 - $44,838	241 Added 12.79%	2,126 $319,000
Q3 2022 Nov 10, 2022	BUY	$127.65 - $183.11 $13,530 - $19,409	106 Added 5.96%	1,885 $254,000
Q2 2022 Aug 09, 2022	BUY	$123.25 - $186.24 $20,952 - $31,660	170 Added 10.57%	1,779 $265,000
Q1 2022 May 11, 2022	BUY	$126.25 - $231.85 $23,735 - $43,587	188 Added 13.23%	1,609 $274,000
Q4 2021 Feb 10, 2022	BUY	$216.64 - $362.52 $4,766 - $7,975	22 Added 1.57%	1,421 $366,000
Q3 2021 Nov 08, 2021	BUY	$205.93 - $447.23 $4,530 - $9,839	22 Added 1.6%	1,399 $380,000
Q2 2021 Aug 10, 2021	BUY	$113.32 - $241.49 $156,041 - $332,531	1,377 New	1,377 $308,000

Others Institutions Holding BNTX

# of Institutions

374

Shares Held

40.2M

Call Options Held

3.32M

Put Options Held

2.26M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Midwest Professional Planners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Midwest Professional Planners, Ltd. with notifications on news.

Account

Midwest Professional Planners, Ltd. Bio N Tech Se Transaction History